Patience David
SEC CIK 1970009 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | CFO | 261.1K | $32.2K | — | 5 | 2025-08-14 | 2026-07-01 |
Most active insiders at TLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stansky Michael P | Dir | $3.01M | — |
| 2 | Szela Mary T | CEO, Pres, Dir | $227.8K | $79.4K |
| 3 | Wahlstrom Mats | Dir | $151.8K | — |
| 4 | Valle William | Dir | $125.0K | — |
| 5 | Gordon Gary B. | Dir | $64.6K | — |
| 6 | Patience David | CFO | $32.2K | — |
| 7 | Marshak Richard | Chief Commercial Off | — | $15.7K |
| 8 | Stevens Jennifer | Chief Regulatory Off | — | $14.5K |
| 9 | Devlin Jodi | Chief of Clinical Ops | — | $13.2K |
| 10 | Cox Bryan F. | Chief of Research | — | $13.1K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 16:01 | 2026-07-01 | TLSI | TriSalus Life Sciences, Inc. | Patience David | CFO | F - Tax | $4.46 | -14.7K | 261.1K | -5% | -$65.3K | |
| 2026-05-18 16:42 | 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | Patience David | CFO | P - Purchase | $2.43 | +7,100 | 275.8K | +3% | +$17.3K | |
| 2026-02-23 | 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | Patience David | CFO | P - Purchase | $4.10 | +3,657 | 268.7K | +1% | +$15.0K | |
| D | 2025-11-25 | 2025-11-24 | TLSI | TriSalus Life Sciences, Inc. | Patience David | CFO | A - Grant | $0.00 | +65.0K | 265.0K | +32% | $0 |
| D | 2025-08-15 | 2025-08-14 | TLSI | TriSalus Life Sciences, Inc. | Patience David | CFO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations